← Open Payments lookup

EDWARD CLARK: Open Payments

NPI 1225268907 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$738 in 34 payments from 9 companies in 2025. Trend: 2023 $24 · 2024 $139 · 2025 $738

Food & beverage: $738
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$121
Axsome Therapeutics, Inc.5$121
Janssen Pharmaceuticals, Inc5$116
Lundbeck LLC5$102
Otsuka America Pharmaceutical, Inc.5$91
Bausch Health US, LLC4$71
Neurocrine BioSciences, Inc.2$54
ABBVIE INC.2$39
E.R. Squibb & Sons, L.L.C.1$24

Products named: REXULTI, CAPLYTA, Auvelity, SPRAVATO, WELLBUTRIN, INGREZZA, VRAYLAR, COBENFY.

Industry payments across TX — which companies pay providers there.